A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis.
about
Epigenetic basis of cancer health disparities: Looking beyond genetic differences.Genetic variation in CDH13 gene was associated with non-small cell lung cancer (NSCLC): A population-based case-control study.Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer.CDH13 promoter methylation regulates cisplatin resistance of non-small cell lung cancer cells
P2860
A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Systematic Analysis of the R ...... ast Cancer Risk and Prognosis.
@ast
A Systematic Analysis of the R ...... ast Cancer Risk and Prognosis.
@en
type
label
A Systematic Analysis of the R ...... ast Cancer Risk and Prognosis.
@ast
A Systematic Analysis of the R ...... ast Cancer Risk and Prognosis.
@en
prefLabel
A Systematic Analysis of the R ...... ast Cancer Risk and Prognosis.
@ast
A Systematic Analysis of the R ...... ast Cancer Risk and Prognosis.
@en
P2093
P2860
P31
P921
P1433
P1476
A Systematic Analysis of the R ...... ast Cancer Risk and Prognosis.
@en
P2093
Jingyu Yang
Kunxian Yang
Yingze Huang
P2860
P304
P356
10.1371/JOURNAL.PONE.0149185
P407
P5008
P577
2016-05-06T00:00:00Z